{
  "resourceType": "CodeSystem",
  "status": "draft",
  "content": "complete",
  "name": "CompSectionTypes",
  "id": "sectionType",
  "title": "Composition Section Type",
  "description": "Classification of a sections of a PQ/CMC composition/document generally based on eCTD Module 3 section numbering for product and substance. A composition can have many section codes.",
  "version": "Internal",
  "url": "https://www.hl7.org/fhir/us-pq-cmc/CodeSystem/sectionType",
  "date": "2020-04-06T10:07:08-04:00",
  "publisher": "U.S. Federal Drug Administration",
  "concept": [
    {
      "code": "32S10",
      "display": "Substance General Information"
    },
    {
      "code": "32S11",
      "display": "Substance Nomenclature"
    },
    {
      "code": "32S12",
      "display": "Substance Structure"
    },
    {
      "code": "32S13",
      "display": "Substance General Properties"
    },
    {
      "code": "32S20",
      "display": "Substance Manufacture"
    },
    {
      "code": "32S21",
      "display": "Substance Manufacturers"
    },
    {
      "code": "32S22",
      "display": "Substance Description of Manufacturing Process and Process Controls"
    },
    {
      "code": "32S23",
      "display": "Substance Control of Materials"
    },
    {
      "code": "32S24",
      "display": "Substance Controls of Critical Steps and Intermediates"
    },
    {
      "code": "32S25",
      "display": "Substance Process Validation and/or Evaluation"
    },
    {
      "code": "32S26",
      "display": "Substance Manufacturing Process Development"
    },
    {
      "code": "32S30",
      "display": "Substance Characterization"
    },
    {
      "code": "32S31",
      "display": "Substance Elucidation of Structure and other Characteristics"
    },
    {
      "code": "32S32",
      "display": "Substance Impurities"
    },
    {
      "code": "32S40",
      "display": "Substance Control of Drug Substance"
    },
    {
      "code": "32S41",
      "display": "Substance Specification"
    },
    {
      "code": "32S42",
      "display": "Substance Analytical Procedures"
    },
    {
      "code": "32S43",
      "display": "Substance Validation of Analytical Procedures"
    },
    {
      "code": "32S44",
      "display": "Substance Batch Analyses"
    },
    {
      "code": "32S45",
      "display": "Substance Justification of Specification"
    },
    {
      "code": "32S50",
      "display": "Substance Reference Standards or Materials"
    },
    {
      "code": "32S60",
      "display": "Substance Container Closure System"
    },
    {
      "code": "32S70",
      "display": "Substance Stability"
    },
    {
      "code": "32S71",
      "display": "Substance Stability Summary and Conclusions"
    },
    {
      "code": "32S72",
      "display": "Substance Postapproval Stability Protocol and Stability Commitment"
    },
    {
      "code": "32S73",
      "display": "Substance Stability Data"
    },
    {
      "code": "32P10",
      "display": "Product Description and Composition of the Drug Product"
    },
    {
      "code": "32P20",
      "display": "Product Pharmaceutical Development"
    },
    {
      "code": "32P21",
      "display": "Product Components of the Drug Product"
    },
    {
      "code": "32P22",
      "display": "Product Drug Product"
    },
    {
      "code": "32P23",
      "display": "Product Manufacturing Process Development"
    },
    {
      "code": "32P24",
      "display": "Product Container Closure System"
    },
    {
      "code": "32P25",
      "display": "Product Microbiological Attributes"
    },
    {
      "code": "32P26",
      "display": "Product Compatibility"
    },
    {
      "code": "32P30",
      "display": "Product Manufacture"
    },
    {
      "code": "32P31",
      "display": "Product Manufacturers"
    },
    {
      "code": "32P32",
      "display": "Product Batch Formula"
    },
    {
      "code": "32P33",
      "display": "Product Description of Manufacturing Process and Process Controls"
    },
    {
      "code": "32P34",
      "display": "Product Controls of Critical Steps and Intermediates"
    },
    {
      "code": "32P35",
      "display": "Product Process Validation and/or Evaluation"
    },
    {
      "code": "32P40",
      "display": "Product Control of Excipients"
    },
    {
      "code": "32P41",
      "display": "Excipients Specifications"
    },
    {
      "code": "32P42",
      "display": "Product Analytical Procedures"
    },
    {
      "code": "32P43",
      "display": "Product Validation of Analytical Procedures"
    },
    {
      "code": "32P44",
      "display": "Product Justification of Specifications"
    },
    {
      "code": "32P45",
      "display": "Product Excipients of Human or Animal Origin"
    },
    {
      "code": "32P46",
      "display": "Product Novel Excipients"
    },
    {
      "code": "32P50",
      "display": "Product name - dosage form"
    },
    {
      "code": "32P51",
      "display": "Product Specifications"
    },
    {
      "code": "32P52",
      "display": "Product Analytical Procedures"
    },
    {
      "code": "32P53",
      "display": "Product Validation of Analytical Procedures"
    },
    {
      "code": "32P54",
      "display": "Product Batch Analyses"
    },
    {
      "code": "32P55",
      "display": "Product Characterization of Impurities"
    },
    {
      "code": "32P56",
      "display": "Product Justification of Specifications"
    },
    {
      "code": "32P60",
      "display": "Product Reference Standards or Materials"
    },
    {
      "code": "32P70",
      "display": "Product Container Closure System"
    },
    {
      "code": "32P80",
      "display": "Product Stability"
    },
    {
      "code": "32P81",
      "display": "Product Stability Summary and Conclusion"
    },
    {
      "code": "32P82",
      "display": "Product Postapproval Stability Protocol and Stability Commitment"
    },
    {
      "code": "32P83",
      "display": "Product Stability Data"
    },
    {
      "code": "SP4151",
      "display": "Quality Specification"
    }
  ],
  "count": 61
}
